Can you explain each prenatal ultrasound scan used in India—including ultrasound (USG), growth scan, anomaly scan, nuchal translucency (NT) scan, Doppler study, and biophysical profile (BPP)—and specify how to describe them to a pregnant mother and which trimester each is performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prenatal Ultrasound Scans in Indian Pregnancy Care: A Trimester-by-Trimester Guide

First Trimester (11-14 weeks): NT Scan and Early Anatomy Assessment

The NT (Nuchal Translucency) scan should be performed between 11-14 weeks and is your most powerful first-trimester screening tool for chromosomal abnormalities and early structural defects 1.

How to Explain to Mothers:

  • "This scan measures the fluid space at the back of your baby's neck. A measurement above 3.5 mm significantly increases risk of Down syndrome and other chromosomal problems—with a 20-fold increased risk even between 3.0-3.5 mm" 2
  • "We can detect 91% of lethal abnormalities at this early stage, though overall sensitivity for all structural problems is only 37.5%" 3
  • "This scan also confirms your due date, checks if you're carrying twins, and evaluates early fetal anatomy"

What You're Assessing:

  • Crown-rump length for dating
  • NT measurement (abnormal if ≥3.0 mm, with risk increasing progressively) 1, 2
  • Basic anatomical survey (can detect 22% of major structural anomalies at this stage) 4
  • Chorionicity in twin pregnancies

Critical Pitfall: Even NT measurements between 2.0-3.0 mm carry increased risk compared to <2.0 mm, so don't falsely reassure mothers with "borderline" measurements 2.


Second Trimester (18-23 weeks): Anomaly Scan (Level II Detailed Scan)

The anomaly scan at 18-23 weeks is your primary screening tool for fetal structural abnormalities and must be performed in all pregnancies 5.

How to Explain to Mothers:

  • "This is the most detailed scan of pregnancy where we examine every organ system of your baby"
  • "We check the brain, spine, heart (four-chamber view), kidneys, stomach, limbs, and face"
  • "This scan detects approximately 55% of major malformations when done alone, but combined with your first-trimester scan, we can detect 69% of structural problems" 5, 4
  • "We also check your placenta position and amniotic fluid levels"

What You're Assessing:

  • Detailed fetal anatomy survey of all organ systems
  • Fetal growth parameters (biparietal diameter, head circumference, abdominal circumference, femur length)
  • Placental location and maturity
  • Amniotic fluid volume
  • Cervical length if indicated

Common Pitfall: CNS malformations are the most commonly detected anomalies in India (35-69% of all detected malformations), followed by genitourinary and gastrointestinal abnormalities 6. Cardiovascular malformations require specific expertise and may need fetal echocardiography.


Second/Third Trimester: Growth Scans (Serial Biometry)

Growth scans should be performed every 3-4 weeks starting from 28 weeks in high-risk pregnancies, or as a single scan at 32-36 weeks in low-risk pregnancies 7.

How to Explain to Mothers:

  • "We measure your baby's head, abdomen, and thigh bone to estimate weight and ensure proper growth"
  • "We're checking if your baby is growing appropriately for the gestational age"
  • "Small babies (growth restriction) or large babies (macrosomia) may need special monitoring or delivery planning"

What You're Assessing:

  • Estimated fetal weight (EFW)
  • Growth velocity (comparing with previous scans)
  • Amniotic fluid index (AFI)
  • Placental grading

In the Indian context: Routine third-trimester scanning detected abnormalities in 52.5% of clinically low-risk pregnancies that would have been missed otherwise 7.


Third Trimester: Doppler Studies (Selective, Not Routine)

Doppler ultrasound is NOT a routine scan—it should be reserved for high-risk pregnancies with suspected fetal growth restriction, hypertension, or other complications 5, 8.

How to Explain to Mothers:

  • "This special scan checks blood flow in the umbilical cord and baby's brain vessels"
  • "We use this when we're concerned about your baby's growth or if you have high blood pressure"
  • "It helps us decide the safest timing for delivery"

Indications for Doppler:

  • Suspected fetal growth restriction (EFW <10th percentile)
  • Maternal hypertensive disorders (preeclampsia, chronic hypertension)
  • Abnormal amniotic fluid (oligohydramnios/polyhydramnios)
  • Twin-twin transfusion syndrome in monochorionic twins
  • Suspected fetal anemia (Rh isoimmunization)

What You're Assessing:

  • Umbilical artery Doppler (resistance index, pulsatility index)
  • Middle cerebral artery Doppler
  • Cerebroplacental ratio (CPR <1.0 is abnormal and has 97.8% specificity for adverse outcomes) 7
  • Uterine artery Doppler
  • Ductus venosus in severe cases

Critical Point: Doppler has the highest ultrasound output energy and should only be used when medically indicated, not as routine screening 5.


Third Trimester: Biophysical Profile (BPP) (Selective)

BPP should be performed for fetal surveillance in high-risk pregnancies, typically starting at 32-34 weeks, often combined with NST as Modified BPP 9.

How to Explain to Mothers:

  • "This test checks your baby's well-being by looking at five things: breathing movements, body movements, muscle tone, amniotic fluid, and heart rate pattern"
  • "Each component gets 2 points; a score of 8-10 is reassuring, 6 is equivocal, and ≤4 suggests your baby may be in distress"
  • "We often combine this with the heart rate monitoring (NST) for better accuracy"

Components of BPP:

  1. Fetal breathing movements (≥1 episode of ≥30 seconds in 30 minutes)
  2. Fetal body movements (≥3 discrete movements in 30 minutes)
  3. Fetal tone (≥1 episode of extension/flexion)
  4. Amniotic fluid volume (single deepest pocket ≥2 cm)
  5. Non-stress test (reactive)

Modified BPP (More Practical):

  • NST + Amniotic Fluid Index only
  • Sensitivity for non-reassuring fetal status is 60% for MBP alone, but increases to 70% when combined with umbilical artery Doppler 9

Key Evidence: Modified BPP combined with Doppler is superior to either test alone for predicting adverse perinatal outcomes 9.


Two-Stage vs. Single-Stage Screening: The Evidence

Two-stage screening (first-trimester NT scan + second-trimester anomaly scan) detects 83.8% of structural anomalies before 24 weeks, compared to only 50.5% with single second-trimester scan alone 3.

  • Two-stage approach: 1,448 correct detections per 1,776 anomalies (83.8%)
  • Single-stage approach: 896 correct detections per 1,776 anomalies (50.5%)
  • This represents 592 additional anomalies detected with two-stage screening

The specificity remains excellent for both approaches (>99.8%), so false positives are not a concern 3.


Practical Algorithm for Indian Practice

All Pregnancies (Low-Risk):

  1. 11-14 weeks: NT scan + early anatomy
  2. 18-23 weeks: Detailed anomaly scan (Level II)
  3. 32-36 weeks: Single growth scan (consider routine third-trimester scan given Indian data showing 52.5% detection of previously unidentified abnormalities) 7

High-Risk Pregnancies (Add):

  1. Serial growth scans every 3-4 weeks from 28 weeks
  2. Doppler studies when growth restriction, hypertension, or other complications suspected
  3. Modified BPP (NST + AFI) weekly or twice-weekly from 32-34 weeks
  4. Consider adding umbilical artery Doppler to MBP for 70% sensitivity in detecting fetal compromise 9

Important Context for India: Only 35% of Level II scans are performed by obstetricians in India, with most done by radiologists 6. Ensure proper training and standardization of protocols for optimal detection rates.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.